Activating or loss of function mutations in the HH pathway genes SMO and PTCH1 occur in human gastric tumors [119], sporadic BCC [120], medulloblastoma, nevoid basal cell carcinoma syndrome (NBCCS), and colorectal cancer [121]. This evidence concerns the gene PTCH1 and nevoid basal cell carcinoma syndrome.